KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Edwards Lifesciences (EW) Gross Margin (2016 - 2025)

Historic Gross Margin for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to 77.77%.

  • Edwards Lifesciences' Gross Margin fell 28200.0% to 77.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 78.19%, marking a year-over-year decrease of 15800.0%. This contributed to the annual value of 79.46% for FY2024, which is 10200.0% down from last year.
  • Edwards Lifesciences' Gross Margin amounted to 77.77% in Q3 2025, which was down 28200.0% from 77.52% recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Gross Margin registered a high of 122.98% during Q4 2022, and its lowest value of 75.7% during Q2 2021.
  • In the last 5 years, Edwards Lifesciences' Gross Margin had a median value of 78.91% in 2024 and averaged 81.05%.
  • In the last 5 years, Edwards Lifesciences' Gross Margin soared by 462600bps in 2022 and then crashed by -428000bps in 2023.
  • Over the past 5 years, Edwards Lifesciences' Gross Margin (Quarter) stood at 76.72% in 2021, then surged by 60bps to 122.98% in 2022, then plummeted by -35bps to 80.18% in 2023, then dropped by -2bps to 78.91% in 2024, then decreased by -1bps to 77.77% in 2025.
  • Its Gross Margin was 77.77% in Q3 2025, compared to 77.52% in Q2 2025 and 78.65% in Q1 2025.